Cargando…
M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
Autores principales: | Szafron, V., Pereira, M., Vogel, T., Leung, D., Forbes-Satter, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661922/ http://dx.doi.org/10.1016/j.anai.2020.08.359 |
Ejemplares similares
-
Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children
por: Studzińska, Mirosława, et al.
Publicado: (2017) -
Proceedings of the Euromech Colloquium 412
por: Friedrich, R, et al.
Publicado: (2004) -
Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
por: Popping, Stephanie, et al.
Publicado: (2019) -
Oral leukoplakia, a clinical-histopathological study in 412 patients
por: Rubert, Andrea, et al.
Publicado: (2020) -
Retraction: Oral leukoplakia, a
clinical-histopathological study in 412
patients
por: Rubert, Andrea, et al.
Publicado: (2021)